Speakers

Featured Speakers

• Dr. Victor Dzau
  Chancellor for Health Affairs, Duke University
  President and CEO, Duke University Health System
• David Malakoff
  Technology and Science Correspondent
  National Public Radio (NPR)
• Dr. Henri B. Meier
  Chairman of the Board of Directors
  HBM Partners AG and HBM BioVentures AG
• Dr. Tanja Popovic
  Acting Associate Director for Science
  The Centers for Disease Control and Prevention (CDC)

Panel Session Speakers (partial list):

• Paul W. Allen, VP, Managing Partner Life Sciences, Clarkston Consulting
• Charles Baltic, Managing Director, Healthcare Investment Banking, Wachovia Securities
• George Christ, Ph.D., Professor of Regenerative Medicine, Urology and Physiology & Pharmacology; Head of the Cell, Tissue & Organ Physiology Program, Wake Forest University Baptist Medical Center
• Jeff Clark, Managing Partner, The Aurora Funds, Inc.
• Michael Constantino, Audit Partner, Ernst & Young LLP
• Donald deBethizy, Ph.D., President and CEO, Targacept, Inc.
• Lou Anne Flanders-Stec, Fund Executive, Piedmont Angel Network (PAN)
• Federico Goodsaid, Ph.D., Senior Staff Scientist, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration (FDA)
• Robert Helms, Ph.D., Director, Strategic Initiatives Engineering Group, RTI International
• Hans Houser, Vice President of Portfolio and Credit, Oxford Finance Corporation
• Deborah Hylton, Partner, Womble Carlyle Sandridge & Rice PLLC
• Joseph Izatt, Ph.D., Associate Professor, Biomedical Engineering Department, Duke University
• Richard Kouri, Ph.D., President, CEO and Co-Founder, Nanolytics, Inc.
• Russ Lea, Ph.D., Vice President for Research and Sponsored Programs, University of North Carolina
• Randall Marcuson, President and Chief Executive Officer, Embrex, Inc.
• Sheila Mikhail, Chief Executive Officer, Asklepios Biopharmaceutical, Inc.
• Amit Munshi, President, Adrista Inc.
• Michael Murphy, President and Chief Executive Officer, Gentris Corporation
• Nader Naeymi-Rad, Senior Vice President, Brand Management Practice, Campbell Alliance
• Laura Reid, Ph.D., Director, Research and Development, Expression Analysis
• John Richert, Vice President, Business and Technology Development, North Carolina Biotechnology Center
• Lee Stettner, Managing Director, Head of Healthcare Investment Banking, Deutsche Bank
• Kenneth Tindall, Ph.D., Senior Vice President for Science and Business Development, North Carolina Biotechnology Center
• Kay Wagoner, Ph.D., Co-Founder and Chief Executive Officer, Icagen, Inc.
• Michael Walter, Ph.D., Senior Staff Scientist, Joint Program Executive Office for Chemical/Biological Defense
• Terry Williams, Chief Development Officer, Hemoscience Inc.

Click here to see last year's impressive line-up of speakers!